English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Erianne Leatherman | Mar 24, 2017

Arriva Medical considering appeal options following court's ruling

Gene Johnson | Mar 24, 2017

Pfizer's antibiotic drug Zavicefta available in Germany, United Kingdom

Gene Johnson | Mar 24, 2017

AstraZeneca, Circassia Pharmaceuticals partner to develop respiratory drugs

Gene Johnson | Mar 24, 2017

Horizon Pharma launches initiative for people with rare genetic disease

Gene Johnson | Mar 24, 2017

China approves Xeljanz to treat moderate to severe rheumatoid arthritis

Gene Johnson | Mar 24, 2017

Japan to review drug for the treatment of chronic hepatitis C

Gene Johnson | Mar 24, 2017

FDA approves new drug for the treatment of advanced breast cancer in women

Robert Hadley | Mar 23, 2017

Eli Lilly’s Taltz show better results than rival Stelara in clinical trials

Trending

+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'

Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’

  • « First
  • «
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily